
[Cancer Research 55, 2316-2324, June 1, 1995]
© 1995 American Association for Cancer Research
DNA Adduct Formation and T-Lymphocyte Mutation Induction in F344 Rats Implanted with Tumorigenic Doses of 1,6-Dinitropyrene1
Beverly A. Smith,
Nancy F. Fullerton,
Robert H. Heflich and
Frederick A. Beland2
National Center for Toxicological Research, Jefferson, Arkansas 72079
Diesel emissions are known to induce tumors in experimental animals and are suspected of being carcinogenic in humans. Of the compounds associated with diesel exhaust, 1,6-dinitropyrene is a particularly potent mutagen and carcinogen. In these experiments, we have investigated the use of DNA adducts and T-lymphocyte mutations of 1,6-dinitropyrene as biomarkers for exposure to diesel emissions. 1,6-Dinitropyrene (0150 µg) was applied directly to the lungs of male F344 rats according to a protocol known to induce lung tumors. In target (lung) and surrogate (liver, WBC, and spleen lymphocytes) tissues, one major DNA adduct, N-(deoxyguanosin-8-yl)-1-amino-6-nitropyrene, was detected by HPLC and/or 32P-post-labeling analyses. The levels of this adduct reached a maximum 17 days following treatment and decreased to 1350% of the peak values by 28 days after dosing. In the lung, a 2-fold increase in dose resulted in a 2-fold increase in DNA binding up to the 30-µg dose; in the liver the same relationship was observed up to 10 µg 1,6-dinitropyrene. At higher doses, the extent of adduct formation still increased, but the rate was much lower than that occurring at lower doses. A limiting dilution clonal assay was used to measure mutation induction at the hypoxanthine-guanine phosphoribosyltransferase locus in spleen T lymphocytes. Following treatment, the mutant frequency increased until 21 weeks, remained constant until week 40, and then began to decrease. Mutant induction was dose related, with the increase in mutant frequency being significant at doses
1 µg 1,6-dinitropyrene. These data indicate that 1,6-dinitropyrene, a constituent of diesel emissions, is metabolically activated by nitroreduction to give DNA adducts in target and surrogate tissues. They further suggest that T-lymphocyte mutations may be a more sensitive and longer-lived biomarker than DNA adducts for assessing previous exposures to nitropolycyclic aromatic hydrocarbons.
1 Part of the research described in this article was conducted under contract to the Health Effects Institute, an organization jointly funded by the United States Environmental Protection Agency under Assistance Agreement X812059 and automotive manufacturers. The contents of this article do not necessarily reflect the views of the Health Effects Institute, nor do they necessarily reflect the policies of the Environmental Protection Agency or automotive manufacturers. Preliminary accounts of this work have appeared in Environ. Health Perspect. 99: 277280, 1993 and 102 (Suppl 6): 185189, 1994.
2 To whom requests for reprints should be addressed, at HFT-110, National Center for Toxicological Research, 3900 NCTR Road, Jefferson, AR 72079.
Received 1/ 9/95.
Accepted 3/31/95.
This article has been cited by other articles:

|
 |

|
 |
 
C. A. Bieler, M. G. Cornelius, M. Stiborova, V. M. Arlt, M. Wiessler, D. H. Phillips, and H. H. Schmeiser
Formation and persistence of DNA adducts formed by the carcinogenic air pollutant 3-nitrobenzanthrone in target and non-target organs after intratracheal instillation in rats
Carcinogenesis,
May 1, 2007;
28(5):
1117 - 1121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Nagy, M. Zeisig, K. Kawamura, Y. Hisamatsu, A. Sugeta, S. Adachi, and L. Moller
DNA adduct and tumor formations in rats after intratracheal administration of the urban air pollutant 3-nitrobenzanthrone
Carcinogenesis,
October 1, 2005;
26(10):
1821 - 1828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Boudreau, D. G. Baker, H. W. Taylor, S. A. Barker, and J. C. Means
Suppression of Arylamine Toxicity in the Fischer-344 Rat Following Ingestion of a Complex Mixture
Toxicol Pathol,
April 1, 2001;
29(3):
333 - 343.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Chen, A. Aidoo, R. A. Mittelstaedt, D. A. Casciano, and R. H. Heflich
Hprt mutant frequency and molecular analysis of Hprt mutations in Fischer 344 rats treated with thiotepa
Carcinogenesis,
February 1, 1999;
20(2):
269 - 277.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Association for Cancer Research.